Related Experiment Videos

[Recurrent pneumococcal meningitis after splenectomy]

M Gerwig1, A Wittkämper, U Liebetrau

  • 1Neurologische Klinik, Kliniken der Stadt Köln.

Der Nervenarzt
|October 1, 1994
PubMed

Insights

Splenectomy for Werlhof's disease can lead to recurrent pneumococcal meningitis, particularly from vaccine-excluded type 13. Careful consideration of splenectomy necessity and post-operative infection risk is crucial for patients.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Hematology

Background:

  • Werlhof's disease, also known as immune thrombocytopenic purpura, is an autoimmune disorder.
  • Splenectomy is a potential treatment option for refractory cases of immune thrombocytopenic purpura.
  • Post-splenectomy infections, especially encapsulated bacteria, represent a significant clinical concern.

Observation:

  • A patient with Werlhof's disease underwent splenectomy.
  • Following splenectomy, the patient developed recurrent pneumococcal meningitis.
  • The causative agent was identified as Streptococcus pneumoniae capsular type 13.

Findings:

  • Pneumococcal type 13 is not covered by the standard 23-valent pneumococcal polysaccharide vaccine.
  • Splenectomy significantly increases the risk of severe infections, including meningitis.
  • Recurrent infections highlight the importance of vaccine-preventable pathogens post-splenectomy.

Implications:

  • The decision for splenectomy in autoimmune diseases requires careful risk-benefit assessment.
  • Patients undergoing splenectomy must be thoroughly counseled on the heightened risk of infection.
  • Prophylactic and immediate medical treatment for infections post-splenectomy is essential, considering non-vaccine serotypes.

Related Concept Videos